Phenol-Soluble Modulin Toxins of Staphylococcus haemolyticus

被引:32
作者
Da, Fei [1 ,2 ]
Joo, Hwang-Soo [1 ]
Cheung, Gordon Y. C. [1 ]
Villaruz, Amer E. [1 ]
Rohde, Holger [3 ]
Luo, Xiaoxing [2 ]
Otto, Michael [1 ]
机构
[1] NIAID, Pathogen Mol Genet Sect, Lab Bacteriol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Fourth Mil Med Univ, Dept Pharmacol, Sch Pharm, Xian, Peoples R China
[3] Univ Hosp Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2017年 / 7卷
基金
美国国家卫生研究院;
关键词
Staphylococcus haemolyticus; coagulase-negative staphylococci; phenol-soluble modulin; toxin; hemolysin; leukocidin; GONOCOCCAL GROWTH INHIBITOR; AUREUS; EPIDERMIDIS; PEPTIDES; DETERMINANTS; EVOLUTION; INSIGHT; ALPHA-3;
D O I
10.3389/fcimb.2017.00206
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Coagulase-negative staphylococci (CoNS) are important nosocomial pathogens and the leading cause of sepsis. The second most frequently implicated species, after Staphylococcus epidermidis, is Staphylococcus haemolyticus. However, we have a significant lack of knowledge about what causes virulence of S. haemolyticus, as virulence factors of this pathogen have remained virtually unexplored. In contrast to the aggressive pathogen Staphylococcus aureus, toxin production has traditionally not been associated with CoNS. Recent findings have suggested that phenol-soluble modulins (PSMs), amphipathic peptide toxins with broad cytolytic activity, are widespread in staphylococci, but there has been no systematic assessment of PSM production in CoNS other than S. epidermidis. Here, we identified, purified, and characterized PSMs of S. haernolyticus. We found three PSMs of the beta-type, which correspond to peptides that before were described to have anti-gonococcal activity. We also detected an u-type PSM that has not previously been described. Furthermore, we confirmed that S. haemolyticus does not produce delta-toxin, as results from genome sequencing had indicated. All four S. haemolyticus PSMs had strong pro-inflammatory activity, promoting neutrophil chemotaxis. Notably, we identified in particular the novel alpha-type PSM, S. haemolyticus PSM alpha, as a potent hemolysin and leukocidin. For the first time, our study describes toxins of this important staphylococcal pathogen with the potential to have a significant impact on virulence during blood infection and sepsis.
引用
收藏
页数:11
相关论文
共 36 条
  • [1] Coagulase-Negative Staphylococci
    Becker, Karsten
    Heilmann, Christine
    Peters, Georg
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2014, 27 (04) : 870 - 926
  • [2] Essential Staphylococcus aureus toxin export system
    Chatterjee, Som S.
    Joo, Hwang-Soo
    Duong, Anthony C.
    Dieringer, Thomas D.
    Tan, Vee Y.
    Song, Yan
    Fischer, Elizabeth R.
    Cheung, Gordon Y. C.
    Li, Min
    Otto, Michael
    [J]. NATURE MEDICINE, 2013, 19 (03) : 364 - 367
  • [3] Phenol-soluble modulins - critical determinants of staphylococcal virulence
    Cheung, Gordon Y. C.
    Joo, Hwang-Soo
    Chatterjee, Som S.
    Otto, Michael
    [J]. FEMS MICROBIOLOGY REVIEWS, 2014, 38 (04) : 698 - 719
  • [4] Insight into structure-function relationship in phenol-soluble modulins using an alanine screen of the phenol-soluble modulin ( PSM) α3 peptide
    Cheung, Gordon Y. C.
    Kretschmer, Dorothee
    Queck, Shu Y.
    Joo, Hwang-Soo
    Wang, Rong
    Duong, Anthony C.
    Nguyen, Thuan H.
    Bach, Thanh-Huy L.
    Porter, Adeline R.
    DeLeo, Frank R.
    Peschel, Andreas
    Otto, Michael
    [J]. FASEB JOURNAL, 2014, 28 (01) : 153 - 161
  • [5] Staphylococcus epidermidis Strategies to Avoid Killing by Human Neutrophils
    Cheung, Gordon Y. C.
    Rigby, Kevin
    Wang, Rong
    Queck, Shu Y.
    Braughton, Kevin R.
    Whitney, Adeline R.
    Teintze, Martin
    DeLeo, Frank R.
    Otto, Michael
    [J]. PLOS PATHOGENS, 2010, 6 (10)
  • [6] Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children
    Cheung, Gordon Y. C.
    Otto, Michael
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2010, 23 (03) : 208 - 216
  • [7] Staphylococcus haemolyticus - an emerging threat in the twilight of the antibiotics age
    Czekaj, Tomasz
    Ciszewski, Marcin
    Szewczyk, Eligia M.
    [J]. MICROBIOLOGY-SGM, 2015, 161 : 2061 - 2068
  • [8] Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent
    de Haas, CJC
    Veldkamp, KE
    Peschel, A
    Weerkamp, F
    Van Wamel, WJB
    Heezius, ECJM
    Poppelier, MJJG
    Van Kessel, KPM
    van Strijp, JAG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (05) : 687 - 695
  • [9] Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI [10.1007/s00134-007-0934-2, 10.1097/01.CCM.0000298158.12101.41, 10.1007/s00134-008-1040-9]
  • [10] Recognition of Staphylococcus aureus by the innate immune system
    Fournier, B
    Philpott, DJ
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (03) : 521 - +